QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NYSE:LCI

Lannett (LCI) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free LCI Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$0.65
▼
$2.51
52-Week Range
N/A
Volume
280,600 shs
Average Volume
92,067 shs
Market Capitalization
$7.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
LCI stock logo

About Lannett Stock (NYSE:LCI)

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

LCI Stock News Headlines

September 20, 2023 | wsj.com
Lucky Core Industries Ltd.
September 15, 2023 | thestreet.com
Lannett (LCI) Stock Sinks on Lowered Guidance, Canaccord Downgrade
April 19, 2024 | Behind the Markets (Ad)
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
May 1, 2023 | finance.yahoo.com
Lannett Company, Inc. Enters Into Restructuring Support Agreement
April 20, 2023 | finance.yahoo.com
NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGS
April 4, 2023 | finance.yahoo.com
LANNETT SHARES UPDATE
February 26, 2023 | thestreet.com
Why Lannett (LCI) Stock Is Down Today
February 7, 2023 | finance.yahoo.com
Recent uptick might appease Lannett Company, Inc. (NYSE:LCI) institutional owners after losing 26% over the past year
April 19, 2024 | Behind the Markets (Ad)
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
February 2, 2023 | finance.yahoo.com
Lannett Company, Inc. (NYSE:LCI) Q2 2023 Earnings Call Transcript
February 1, 2023 | finance.yahoo.com
LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCE
February 1, 2023 | finance.yahoo.com
Lannett (LCI) Reports Q2 Loss, Tops Revenue Estimates
January 25, 2023 | finance.yahoo.com
LANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLIT
January 25, 2023 | finance.yahoo.com
LANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1
January 4, 2023 | finance.yahoo.com
LANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTS
November 9, 2022 | finance.yahoo.com
Lannett Company First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
November 7, 2022 | finance.yahoo.com
LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAM
November 2, 2022 | finance.yahoo.com
LANNETT REPORTS BETTER THAN EXPECTED FINANCIAL RESULTS FOR FISCAL 2023 FIRST-QUARTER; REITERATES FULL-YEAR GUIDANCE
October 26, 2022 | finance.yahoo.com
LANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2
October 21, 2022 | finance.yahoo.com
LANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO® AT SEYMOUR PLANT
October 19, 2022 | prnewswire.com
LANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGS - PR Newswire
October 19, 2022 | finance.yahoo.com
LANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGS
October 15, 2022 | seekingalpha.com
LCI Lannett Company, Inc.
October 5, 2022 | finance.yahoo.com
Lannett Company, Inc. (LCI)
September 28, 2022 | law360.com
Ex-Pharma CEO Denied 3rd Circ. Rehearing In $1M FBAR Case - Law360
September 26, 2022 | forbes.com
Probability Of Default Is Rising For High Yield Bonds And Leveraged Loans - Forbes
September 19, 2022 | bloomberg.com
Adderall Shortages in US Spread to Two More Drug Suppliers - Bloomberg
See More Headlines
Receive LCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2021
Today
4/19/2024
Fiscal Year End
6/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:LCI
CUSIP
51601210
CIK
57725
Web
www.lannett.com
Phone
(215) 333-9000
Fax
215-333-9004
Employees
810
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($18.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-231,620,000.00
Net Margins
-62.40%
Pretax Margin
-62.67%
Return on Equity
N/A
Return on Assets
-13.39%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.23
Quick Ratio
1.39

Sales & Book Value

Annual Sales
$340.58 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($23.34) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
10,770,000
Free Float
9,354,000
Market Cap
$7.38 million
Optionable
Optionable
Beta
0.95
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Key Competitors

View All Competitors

LCI Stock Analysis - Frequently Asked Questions

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) announced its earnings results on Wednesday, November, 3rd. The company reported ($1.08) earnings per share for the quarter, missing the consensus estimate of ($1.00) by $0.08. The firm earned $101.53 million during the quarter, compared to the consensus estimate of $98.62 million. During the same period in the previous year, the company earned $0.24 EPS.

When did Lannett's stock split?

Lannett shares reverse split on the morning of Tuesday, February 7th 2023. The 1-4 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

What is Timothy Crew's approval rating as Lannett's CEO?

9 employees have rated Lannett Chief Executive Officer Timothy Crew on Glassdoor.com. Timothy Crew has an approval rating of 28% among the company's employees. This puts Timothy Crew in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Lannett own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include Akorn (AKRX), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA).

This page (NYSE:LCI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Your Money is Not Safe
American Alternative
SHOCKING Crypto Leak…
Crypto 101 Media